Literature DB >> 12095614

Direct addition of BimL to mitochondria does not lead to cytochrome c release.

Olivier Terradillos1, Sylvie Montessuit, David C S Huang, Jean-Claude Martinou.   

Abstract

Pro-apoptotic members of the Bcl-2 family can be subdivided in two classes according to their structure: a group including Bax, Bak, and Bok that display Bcl-2 homology (BH) 1, BH2 and BH3 domains and a second group including Bid (BH3 interacting domain death agonist), Bad, Bim (Bcl-2 interacting mediator of cell death) and several others that contain only a BH3 domain, the BH3-only proteins. The BH3-only proteins have been proposed to activate pro-apoptotic members of the Bax subfamily to trigger a mitochondrial pathway that leads to the release of cytochrome c and other apoptogenic factors. Here we report that the mechanism of action of Bim is different from that of Bid. Although overexpression of Bid or Bim in cells leads to cytochrome c release, only Bid is able to trigger the release of cytochrome c through Bax activation when added directly to isolated mitochondria. Bim(L), although unable to activate Bax, can directly inhibit Bcl-2 or Bcl-x(L). Our data suggest two functional classes of BH3-only proteins: those such as Bid which directly activate Bax-like proteins leading to mitochondrial membrane permeability and apoptosis and those such as Bim which inhibit anti-apoptotic proteins and render the cells more susceptible to apoptogenic stimuli.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095614     DOI: 10.1016/s0014-5793(02)02871-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Induction of apoptosis in starfish eggs requires spontaneous inactivation of MAPK (extracellular signal-regulated kinase) followed by activation of p38MAPK.

Authors:  Kayoko Sasaki; Kazuyoshi Chiba
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

2.  Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.

Authors:  F Gautier; Y Guillemin; P F Cartron; T Gallenne; N Cauquil; T Le Diguarher; P Casara; F M Vallette; S Manon; J A Hickman; O Geneste; P Juin
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

3.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

4.  Pharmacological manipulation of Bcl-2 family members to control cell death.

Authors:  Anthony Letai
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 5.  Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes.

Authors:  Brian Leber; Jialing Lin; David W Andrews
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

Review 6.  Where killers meet--permeabilization of the outer mitochondrial membrane during apoptosis.

Authors:  Tom Bender; Jean-Claude Martinou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

7.  Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis.

Authors:  Philippe A Parone; Dominic I James; Sandrine Da Cruz; Yves Mattenberger; Olivier Donzé; François Barja; Jean-Claude Martinou
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

8.  Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release.

Authors:  Uma D Vempati; Francisca Diaz; Antoni Barrientos; Sonoko Narisawa; Abdul M Mian; José Luis Millán; Lawrence H Boise; Carlos T Moraes
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

9.  High glucose induces apoptosis via upregulation of Bim expression in proximal tubule epithelial cells.

Authors:  Xiao-Qian Zhang; Jian-Jun Dong; Tian Cai; Xue Shen; Xiao-Jun Zhou; Lin Liao
Journal:  Oncotarget       Date:  2017-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.